the coronavirus disease (COVID-19) hit the country in the last quarter. The spending in fiscal 2020 was forecasted to drop by around two percent considering the further impact of COVID-19. According to the source, the major factor impacting on the pharmaceutical spend would be a decrease in non-COVID-19-related patient visits and doctor consultations.
The pharmaceutical spend in Japan grew by around 2.9 percent in fiscal year 2019 compared to the previous fiscal year, even though the impact of Year-on-year growth of spending in the pharmaceutical market in Japan from fiscal year 2018 to 2019 with a forecast until 2024 (in Japanese billion yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Pharmaceutical spending Japan FY 2018-2024
- Premium Statistic Dermo-cosmetic products sales value distribution in Italy 2021-2022, by category
- Premium Statistic Dermo-cosmetics sales volume in Italy 2021-2022, by category
- Premium Statistic Dermo-cosmetic products sales volume distribution in Italy 2021-2022, by category
- Premium Statistic Forecasted quarterly sales value of pharmaceutical market in China 2020
- Premium Statistic Forecasted growth rate of pharmaceutical sales value in China 2020, by quarter
- Premium Statistic Sales value of pharmaceutical market in China 2018-2023
- Basic Statistic Growth rate of pharmaceutical sales value in China 2018-2023
- Basic Statistic Demand growth in select countries for immunoglobulin 2018
- Basic Statistic Trade balance in high technology sectors of EU countries 2022
About the region
10
- Premium Statistic Daiichi Sankyo's total employees FY 2012-2021
- Premium Statistic Daiichi Sankyo's net income FY 2012-2021
- Premium Statistic Daiichi Sankyo's total assets FY 2012-2021
- Premium Statistic Takeda Pharmaceutical's revenue breakdown FY 2021, by region
- Premium Statistic Takeda Pharmaceutical's net income FY 2012-2021
- Basic Statistic Takeda Pharmaceutical's revenue FY 2012-2021
- Premium Statistic Takeda Pharmaceutical's number of employees FY 2012-2021
- Premium Statistic Takeda Pharmaceutical's total assets FY 2012-2021
- Premium Statistic Otsuka Holdings' revenue share FY 2021, by segment
- Premium Statistic Otsuka Holdings' total assets FY 2012-2021
Selected statistics
4
Other regions
10
- Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
- Basic Statistic Pharmacy sales in Norway by type of good 2022
- Premium Statistic Annual growth rate of health supplements sales value in Italy 2021-2022, by category
- Premium Statistic China's share in U.S imports of select pharma products 2019
- Premium Statistic Most downloaded pharmacy apps in Russia 2022
- Premium Statistic Market share of foreign and domestic pharmaceuticals in Vietnam 2019-2020
- Basic Statistic Value of pharmaceutical sales in Iceland 2001-2021
- Basic Statistic Value of pharmaceutical sales in Switzerland 2002-2022
- Basic Statistic Value of pharmaceutical sales in Finland 2003-2021
- Premium Statistic Revenue of phytopharmaceuticals in Germany in 2022, by sales channel
Related statistics
10
- Premium Statistic Otsuka Holdings' total employees 2012-2021, by location
- Premium Statistic Otsuka Holdings' operating income FY 2012-2021
- Premium Statistic Otsuka Holdings' total employees FY 2012-2021
- Basic Statistic Otsuka Holdings' net sales FY 2012-2021
- Premium Statistic Takeda Pharmaceutical's sales revenue products FY 2020
- Premium Statistic Takeda Pharmaceutical's expenditure on R&D FY 2011-2020
- Premium Statistic Otsuka Holdings' net income 2011-2020
- Premium Statistic Sawai's drug sales share in Japan FY 2018, by institution
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
Further related statistics
9
- Merck & Co - expenditure on research and development 2006-2022
- Merck & Co total assets 2009-2022
- Merck & Co cash dividends declared 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens operating income in the U.S. 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
- Revenue share from tourism in India 2013-2021, by segment
- Leading countries in the MEA in the Travel & Tourism Competitiveness Index 2018
- Chinese insulin market distribution: leading companies 2011
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2022
- Merck & Co total assets 2009-2022
- Merck & Co cash dividends declared 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens operating income in the U.S. 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2022
- Revenue share from tourism in India 2013-2021, by segment
- Leading countries in the MEA in the Travel & Tourism Competitiveness Index 2018
- Chinese insulin market distribution: leading companies 2011
IQVIA. (April 22, 2020). Year-on-year growth of spending in the pharmaceutical market in Japan from fiscal year 2018 to 2019 with a forecast until 2024 (in Japanese billion yen) [Graph]. In Statista. Retrieved September 27, 2023, from https://www.statista.com/statistics/1119267/japan-growth-rate-pharmaceutical-spend/
IQVIA. "Year-on-year growth of spending in the pharmaceutical market in Japan from fiscal year 2018 to 2019 with a forecast until 2024 (in Japanese billion yen)." Chart. April 22, 2020. Statista. Accessed September 27, 2023. https://www.statista.com/statistics/1119267/japan-growth-rate-pharmaceutical-spend/
IQVIA. (2020). Year-on-year growth of spending in the pharmaceutical market in Japan from fiscal year 2018 to 2019 with a forecast until 2024 (in Japanese billion yen). Statista. Statista Inc.. Accessed: September 27, 2023. https://www.statista.com/statistics/1119267/japan-growth-rate-pharmaceutical-spend/
IQVIA. "Year-on-year Growth of Spending in The Pharmaceutical Market in Japan from Fiscal Year 2018 to 2019 with a Forecast until 2024 (in Japanese Billion Yen)." Statista, Statista Inc., 22 Apr 2020, https://www.statista.com/statistics/1119267/japan-growth-rate-pharmaceutical-spend/
IQVIA, Year-on-year growth of spending in the pharmaceutical market in Japan from fiscal year 2018 to 2019 with a forecast until 2024 (in Japanese billion yen) Statista, https://www.statista.com/statistics/1119267/japan-growth-rate-pharmaceutical-spend/ (last visited September 27, 2023)
Year-on-year growth of spending in the pharmaceutical market in Japan from fiscal year 2018 to 2019 with a forecast until 2024 (in Japanese billion yen) [Graph], IQVIA, April 22, 2020. [Online]. Available: https://www.statista.com/statistics/1119267/japan-growth-rate-pharmaceutical-spend/